UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 861177
NEW YORK, NY
Position in ACAD
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,605,235
-$881,876 QoQ
Shares Held
206,884
+0.7% QoQ
Ownership
0.121%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 40.25879236673692.ToString("F0")%
Shared 0.ToString("F0")%
None 59.74120763326308.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,287,037,771 across 211 Biotechnology names. ACAD ranks #68 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,057,396 | $1,365,249,602 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
723,621 | $559,098,523 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
677,519 | $224,170,706 | |
| 4 | INSM |
INSMED Inc
|
1,215,025 | $198,680,883 | |
| 5 | RPRX |
Royalty Pharma plc
|
3,095,766 | $148,503,890 | |
| 6 | INCY |
Incyte Corp
|
1,540,913 | $145,030,725 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
1,475,632 | $110,805,201 | |
| 8 | DNLI |
Denali Therapeutics Inc.
|
4,432,314 | $85,100,425 |
All Filings in ACAD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,605,235 | 206,884 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,487,111 | 205,433 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $4,505,190 | 211,115 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,395,962 | 342,882 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,170,037 | 251,056 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $4,020,940 | 219,125 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,918,183 | 189,739 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,535,917 | 217,595 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $2,206,651 | 119,343 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $3,830,713 | 122,348 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,474,602 | 118,743 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,032,427 | 126,615 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $2,382,892 | 126,615 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $2,015,567 | 123,201 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,658,824 | 614,537 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $13,862,194 | 572,345 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $12,650,114 | 541,993 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,703,849 | 463,808 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $11,827,610 | 484,937 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $10,413,523 | 403,625 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $30,731,211 | 574,845 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $24,326,196 | 589,726 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $44,575,626 | 919,654 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $32,769,183 | 775,602 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||